{"anticipatedPostingDate":"2027-04","denomUnitsSelected":"Participants","description":"TTR was defined as time from randomization to the first evidence of PR or CR based on BICR. CR was defined as the disappearance of all target and non-target lesions (non-lymph nodes). All pathological lymph nodes (whether target or non-target) must have a reduction in their short axis \\<10 mm. PR was defined as at least a 30% decrease in the SOD of target lesions, taking as reference the baseline sum diameters.","reportingStatus":"NOT_POSTED","timeFrame":"Approximately 3 years","title":"Time to Response (TTR) as Assessed by BICR","type":"SECONDARY"}